Harm reduction: Dispensing safer use supplies and naloxone at discharge
Policy governing provision of harm reduction supplies (naloxone, safer smoking/snorting/injection kits, fentanyl test strips, etc.) to eligible adult patients with substance use disorder at discharge from Boston Medical Center; applies to nursing and licensed independent practitioners involved in ED, inpatient, observation, L&D triage and outpatient discharges.
No material clinical or coverage changes in this revision.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.